AstraZeneca’s medicine for non-small lung cancer gets EU nod
HQ Team July 5, 2024: The Europen Union has approved AstraZeneca’s Tagrisso along with chemotherapy treatment for lung cancer patients after trials showed
HQ Team July 5, 2024: The Europen Union has approved AstraZeneca’s Tagrisso along with chemotherapy treatment for lung cancer patients after trials showed
Swiss drugmaker, Roche, halted a lung cancer trial after it failed to meet the goal of progression-free survival compared to an existing treatment
The national public health agency of the US has reported a fourth person who was infected in the country with the highly pathogenic
The European Medicines Agency has approved Sanofi S.A.’s Dupixent (dupilumab) therapy as an add-on maintenance treatment for adults with uncontrolled chronic obstructive pulmonary
Scotland's researchers and doctors have performed a non-invasive operation on a patient with Parkinson’s disease using the country’s first ultrasound thalamotomy that allowed
The USFDA has rejected a Biologics License Application from Daiichi Sankyo and Merck & Co., seeking accelerated approval of patritumab deruxtecan to treat
The European Medicines Agency has allowed marketing authorisation for the Covid-19 variant vaccine made by Pfizer and BioNTech SE for children aged six
HQ Team June 27, 2024: A new study has found that the removal of both ovaries can have long-term health consequences The US
HQ Team June 27, 2024:The ongoing debate about the perceived benefits or non-benefits of vitamin supplements has another study that emphasises their nil
In a bid to include an under-represented population, the US drug regulator has advised healthcare firms to improve racial, ethnic and other diversity